Loading…
Annexon, Inc. is projected to rise to $5.13 by 2027, a +1% move from its current price of $5.10. ANNX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $4.90 | $5.10 | $5.31 | +0.07% |
| Aug 3 | $4.82 | $5.10 | $5.40 | +0.14% |
| Aug 4 | $4.76 | $5.11 | $5.48 | +0.21% |
| Aug 5 | $4.71 | $5.11 | $5.54 | +0.27% |
| Aug 6 | $4.67 | $5.11 | $5.60 | +0.34% |
| Aug 7 | $4.63 | $5.12 | $5.65 | +0.41% |
| Aug 8 | $4.60 | $5.12 | $5.70 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.60 | $5.12 | $5.70 | +0.48% |
| Week 2 | $4.42 | $5.14 | $5.98 | +0.96% |
| Week 3 | $4.29 | $5.17 | $6.22 | +1.45% |
| Week 4 | $4.19 | $5.19 | $6.43 | +1.94% |
| Week 5 | $4.11 | $5.22 | $6.63 | +2.43% |
| Week 6 | $4.03 | $5.24 | $6.82 | +2.92% |
| Week 7 | $3.97 | $5.27 | $6.99 | +3.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Annexon, Inc. is a healthcare company described as a clinical-stage biopharmaceutical company that discovers and develops medicines for treating inflammatory-related diseases. It provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of Guillain-Barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and is in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis.
The company is also developing ANX007, an antigen-binding fragment (Fab) in Phase 3 program for geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Annexon, Inc. (ANNX) trades at $4.97 per share with a market cap of $814.3M, ranking 2572. The current price and market position provide a baseline for assessing the stock’s risk and potential trajectory.
A major floor 24.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.6% below — buyers have tended to step in here.
The nearest ceiling, 27.6% above — a clean break opens room to run.
A major ceiling 39.8% above — clearing it would confirm fresh momentum.
Key ANNX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANNX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.06 | Buy | $5.13 | Sell |
| MA 10 | $5.20 | Sell | $5.23 | Sell |
| MA 20 | $5.57 | Sell | $5.36 | Sell |
| MA 50 | $5.36 | Sell | $5.42 | Sell |
| MA 100 | $5.52 | Sell | $5.38 | Sell |
| MA 200 | $5.13 | Sell | $5.03 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.66 | Neutral |
| Stoch RSI (14) | 21.70 | Neutral |
| CCI (20) | -85.58 | Neutral |
| Williams %R (14) | -85.67 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -21.62 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 14.33 | Buy |
| TRIX (15) | -0.04 | Sell |
| Awesome (5,34) | -0.34 | Sell |
| Ultimate (7,14,28) | 44.29 | Neutral |
| Momentum (10) | -0.71 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 5.00 | Buy |
| ADX (14) | 12.94 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 40, with a SMA50 of $5.36 and a SMA200 of $5.09. Support sits at $4.52 and resistance at $6.50. The 30-day range spans from $3.81 to $6.49, illustrating a modestly wide trading band in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.52 | $5.10 | $6.66 | 0% | Neutral | |
| $3.91 | $5.13 | $7.21 | +1% | Neutral | |
| $4.07 | $5.58 | $8.26 | +10% | Neutral | |
| $4.09 | $5.82 | $8.97 | +14% | Neutral | |
| $4.58 | $6.73 | $10.72 | +32% | Bullish | |
| $5.71 | $8.65 | $14.19 | +70% | Bullish | |
| $5.90 | $9.19 | $15.46 | +80% | Bullish | |
| $6.17 | $9.88 | $17.00 | +94% | Bullish | |
| $5.98 | $9.84 | $17.29 | +93% | Bullish | |
| $5.26 | $8.87 | $15.90 | +74% | Bullish | |
| $8.37 | $15.86 | $30.82 | +211% | Bullish | |
| $11.66 | $25.91 | $56.45 | +409% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.52 | $5.10 | $6.16 | +0.00% |
| September 2026 | $4.37 | $5.24 | $6.52 | +2.92% |
| October 2026 | $4.47 | $5.42 | $6.85 | +3.43% |
| November 2026 | $4.30 | $5.26 | $6.73 | -3.00% |
| December 2026 | $4.18 | $5.15 | $6.66 | -2.12% |
Click any year to see its month-by-month ANNX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ANNX could reach as high as $6.66, with a base case around $5.10 and support toward $4.52 — roughly 0% from $5.10. Price action looks broadly range-bound.
Expect ANNX to range from $3.91 to $7.21 through 2027. The $5.13 average target implies a +1% move from current prices. That is up +1% on the projected 2026 average. A consolidation phase looks the most probable path here.
The ANNX price prediction for 2028 points to an average of $5.58 (low $4.07, high $8.26) — a potential gain of +10% on today's $5.10. Price action looks broadly range-bound.
In 2029, ANNX is projected to trade between $4.09 and $8.97, averaging $5.82 — a potential gain of +14% from today's $5.10. That is up +4% on the projected 2028 average. A consolidation phase looks the most probable path here.
Annexon, Inc.'s 2030 outlook centres on $6.73, within a $4.58 to $10.72 range. That is up +16% on the projected 2029 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2031, ANNX could reach as high as $14.19, with a base case around $8.65 and support toward $5.71 — roughly +70% from $5.10. Buyers look set to stay in control over this stretch.
Expect ANNX to range from $5.90 to $15.46 through 2032. The $9.19 average target implies a +80% move from current prices. That is up +6% on the projected 2031 average. Momentum favours further upside here.
The ANNX price prediction for 2033 points to an average of $9.88 (low $6.17, high $17.00) — a potential gain of +94% on today's $5.10. Buyers look set to stay in control over this stretch.
In 2034, ANNX is projected to trade between $5.98 and $17.29, averaging $9.84 — a potential gain of +93% from today's $5.10. That is 0% versus the projected 2033 average. Momentum favours further upside here.
Annexon, Inc.'s 2035 outlook centres on $8.87, within a $5.26 to $15.90 range. That is -10% versus the projected 2034 average. That marks a +74% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ANNX could reach as high as $30.82, with a base case around $15.86 and support toward $8.37 — roughly +211% from $5.10. Momentum favours further upside here.
Expect ANNX to range from $11.66 to $56.45 through 2050. The $25.91 average target implies a +409% move from current prices. That is up +63% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ANNX today (≈ 196.270854 ANNX) could be worth
$5,085.67
+$4,085.67 (+409%) by 2050 · US Dollar
Based on the average projected ANNX price of $25.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANNXwould be worth at today's price.
$1,000 invested in ANNX on Jul 31, 2025 (≈ 416.66665 ANNX) would be worth
$2,122.92
+$1,122.92 (+112.3%) today · 2.12× · US Dollar
Based on a ANNX entry price of $2.4 vs. today's $5.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.22 | $976.05 | -2.4% |
| 1 month ago | $5.55 | $918.02 | -8.2% |
| 3 months ago | $5.75 | $886.09 | -11.4% |
| 6 months ago | $6.38 | $798.59 | -20.1% |
| 1 year ago | $2.4 | $2,122.92 | +112.3% |
| All time (5.0y) ago | $21.54 | $236.54 | -76.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANNX forecast.
Our base-case forecast reaches $10.00 around 2040.
Implied market cap at $10.00: $1.64B
The multi-year forecast points to a bullish trajectory beginning around 2030, with the 2030 average price of $6.53 and a max of $10.42, corresponding to a 31.5% ROI. The forecast continues to lift expectations in subsequent years, with 2040 showing an average of $15.29, a max of $29.72 and a 207.6% ROI, and 2050 projecting an average of $25.05, a max of $54.62 and a 404.1% ROI. Earlier years show more modest moves, with 2026 at an average of $4.97 and a 0% ROI, and the trend remains neutral to bullish as the years progress.
Overall, the outlook suggests substantial upside potential in the farther horizon, balanced by the inherent uncertainty of clinical-stage biopharma timelines and market dynamics.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $6.53 with a min of $4.44 and a max of $10.42, and a projected ROI of 31.5% with a bullish sentiment.
The forecast indicates neutral sentiment for 2026 and 2027-2029, then bullish from 2030 onward, with ROIs of 31.5% in 2030 and 404.1% in 2050. These are estimates, not guarantees.
Yes, the 2030 max is $10.42 and the 2040 max is $29.72, with the 2050 max at $54.62, indicating potential upside beyond $10 in the medium to long term.
The current price is $4.97 per share and the market cap is $814.3M.
The 30-day technical picture is NEUTRAL, with RSI 40, SMA50 $5.36, SMA200 $5.09, support at $4.52, resistance at $6.50, and a 30-day range of $3.81 to $6.49.
Annexon, Inc. Community Discussion
0Share your Annexon, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.